SA 2.1 ctDNA dynamics for early assessment of recurrence risk

SA 2.1 ctDNA dynamics for early assessment of recurrence risk

Bibliographic Details
Main Author:	N. Turner
Format:	Article
Language:	English
Published:	Elsevier 2023-03-01
Series:	Breast
Online Access:	http://www.sciencedirect.com/science/article/pii/S0960977623000747

Similar Items

Association of ctDNA detection and recurrence assessment in patients with neoadjuvant treatment
by: Jiaxin Zhou, et al.
Published: (2023-10-01)

Role of ctDNA in Breast Cancer
by: Marta Sant, et al.
Published: (2022-01-01)

The Role of ctDNA in Gastric Cancer
by: Justin Mencel, et al.
Published: (2022-10-01)

Utility of ctDNA Liquid Biopsies from Cancer Patients: An Institutional Study of 285 ctDNA Samples
by: Josep Gumà, et al.
Published: (2022-11-01)

Methylated ctDNA predicts early recurrence risk in patients undergoing resection of initially unresectable colorectal cancer liver metastases
by: Zhi-Gang Chen, et al.
Published: (2024-02-01)

Enhancing NSCLC recurrence prediction with PET/CT habitat imaging, ctDNA, and integrative radiogenomics-blood insights
by: Sheeba J. Sujit, et al.
Published: (2024-04-01)

Investigate the application of postoperative ctDNA-based molecular residual disease detection in monitoring tumor recurrence in patients with non-small cell lung cancer——A retrospective study of ctDNA
by: Xuefei Zhang, et al.
Published: (2023-04-01)

The circulating tumor DNA (ctDNA) alteration level predicts therapeutic response in metastatic breast cancer: Novel prognostic indexes based on ctDNA
by: Binliang Liu, et al.
Published: (2022-10-01)

Liquid Biopsy, ctDNA Diagnosis through NGS
by: Chen Lin, et al.
Published: (2021-08-01)

State of the Art: ctDNA in Upper Gastrointestinal Malignancies
by: Ibone Labiano, et al.
Published: (2023-02-01)

Potential value of ctDNA monitoring in metastatic HR + /HER2 − breast cancer: longitudinal ctDNA analysis in the phase Ib MONALEESASIA trial
by: Joanne Chiu, et al.
Published: (2023-08-01)

The clinical utility of dynamic ctDNA monitoring in inoperable localized NSCLC patients
by: Yin Yang, et al.
Published: (2022-05-01)

Separation of ctDNA by superparamagnetic bead particles in microfluidic platform for early cancer detection
by: Balakrishnan, S. G., et al.
Published: (2021)

Feasibility of Longitudinal ctDNA Assessment in Patients with Uterine and Extra-Uterine Leiomyosarcoma
by: Maggie Zhou, et al.
Published: (2022-12-01)

Evaluating the Utility of ctDNA in Detecting Residual Cancer and Predicting Recurrence in Patients with Serous Ovarian Cancer
by: Jie Wei Zhu, et al.
Published: (2023-09-01)

Ready for ctDNA-guided treatment decisions in colorectal cancer?
by: Jiaolin Zhou, et al.
Published: (2023-03-01)

Quantitative ctDNA Detection in Hepatoblastoma: Implications for Precision Medicine
by: Smadar Kahana-Edwin, et al.
Published: (2023-12-01)

Emerging ctDNA detection strategies in clinical cancer theranostics
by: Kexin Yi, et al.
Published: (2023-11-01)

The potential, analysis and prospect of ctDNA sequencing in hepatocellular carcinoma
by: Yubo Ding, et al.
Published: (2022-05-01)

CTC, ctDNA, and Exosome in Thyroid Cancers: A Review
by: Wenwen Wang, et al.
Published: (2023-09-01)

Regulatory implications of ctDNA in immuno-oncology for solid tumors
by: Harpreet Singh, et al.
Published: (2023-02-01)

ctDNA: An emerging neoadjuvant biomarker in resectable solid tumors.
by: Christopher Abbosh, et al.
Published: (2021-10-01)

Postoperative ctDNA in indicating the recurrence risk and monitoring the effect of adjuvant therapy in surgical non‐small cell lung cancer
by: Xiaoru Tian, et al.
Published: (2024-04-01)

Corresponding ctDNA and tumor burden dynamics in metastatic melanoma patients on systemic treatment
by: Michael E. Egger, et al.
Published: (2024-04-01)

Circulating Tumor DNA (ctDNA) in Kidney Cancer: A Narrative Review
by: Wesley Yip, et al.
Published: (2023-07-01)

Cerebrospinal fluid ctDNA testing shows an advantage over plasma ctDNA testing in advanced non-small cell lung cancer patients with brain metastases
by: Xiaocui Liu, et al.
Published: (2024-01-01)

The Promise of Circulating Tumor DNA (ctDNA) in the Management of Early-Stage Colon Cancer: A Critical Review
by: Sakti Chakrabarti, et al.
Published: (2020-09-01)

Research progress of CTC, ctDNA, and EVs in cancer liquid biopsy
by: Xiaoling Wang, et al.
Published: (2024-01-01)

ACEK Biosensor for the Minute-Scale Quantification of Breast Cancer ctDNA
by: Ke Wang, et al.
Published: (2024-01-01)

ctDNA-Based Liquid Biopsy of Cerebrospinal Fluid in Brain Cancer
by: Laura Escudero, et al.
Published: (2021-04-01)

The Use of ctDNA in the Diagnosis and Monitoring of Hepatocellular Carcinoma—Literature Review
by: Agnieszka Kopystecka, et al.
Published: (2023-05-01)

ctDNA to Guide Adjuvant Therapy in Localized Colorectal Cancer (CRC)
by: Laura Masfarré, et al.
Published: (2021-06-01)

The Prognostic Importance of ctDNA in Rectal Cancer: A Critical Reappraisal
by: Edina Dizdarevic, et al.
Published: (2022-04-01)

Advances in novel strategies for isolation, characterization, and analysis of CTCs and ctDNA
by: Vahid Yaghoubi Naei, et al.
Published: (2023-09-01)

Prediction of the treatment response in ovarian cancer: a ctDNA approach
by: Mina Sharbatoghli, et al.
Published: (2020-10-01)

Utility and Clinical Application of Circulating Tumor DNA (ctDNA) in Advanced Prostate Cancer
by: Louise Kostos, et al.
Published: (2023-07-01)

Using cfDNA and ctDNA as Oncologic Markers: A Path to Clinical Validation
by: Jonathan Dao, et al.
Published: (2023-08-01)

Opportunities for Early Cancer Detection: The Rise of ctDNA Methylation-Based Pan-Cancer Screening Technologies
by: Nicolas Constantin, et al.
Published: (2022-02-01)

Extensive mutational ctDNA profiles reflect High-grade serous cancer tumors and reveal emerging mutations at recurrence
by: Giovanni Marchi, et al.
Published: (2024-01-01)

Mutated genes on ctDNA detecting postoperative recurrence presented reduced neoantigens in primary tumors in colorectal cancer cases
by: Satoshi Nagayama, et al.
Published: (2023-01-01)